i dont see them as motherhood statements from current FTT management. if i may, I think the current BOD have acted professionally throughout, including the well desiged VF001 trial and the responsible phase down of operations following the UNFORTUNATE results of the trial (including as a result, the BOD not taking any renumeration). The current BOD say they have a way forward, and I trust them to potentially take us in a new direction (still within the biotech space). im not sure what PVDs plan for FTT is.....? But i am disinclined to support their plans for FTT.
thank you,
justaguess
FTT Price at posting:
0.5¢ Sentiment: Buy Disclosure: Not Held
